Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00054210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of chemotherapy is more effective in treating stage IIIB, stage IV, or recurrent non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of polyglutamate paclitaxel plus carboplatin to that of paclitaxel plus carboplatin in treating patients who have stage IIIB, stage IV, or recurrent non-small cell lung cancer.
Study identification
- NCT ID
- NCT00054210
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2003 (Actual)
- Primary completion
- Oct 2004 (Actual)
- Completion
- Oct 2004 (Actual)
- Last update posted
- Oct 5, 2020
2003 – 2004
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology and Oncology Associates of Alabama | Birmingham | Alabama | 35243 | — |
| Clinical Research Consultants, Inc | Hoover | Alabama | 35216 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85712 | — |
| Synergy Hematology/Oncology Medical Associates | Encino | California | 91316 | — |
| Holy Cross Providence Cancer Center | Mission Hills | California | 91345 | — |
| Clinical Trials and Research Associates, Incorporated | Montebello | California | 90640 | — |
| California Hematology/Oncology Medical Group | Torrance | California | 90505 | — |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | — |
| New Hope Cancer Centers | Hudson | Florida | 34667 | — |
| Omni Healthcare, PA | Melbourne | Florida | 32901 | — |
| MetCare Oncology | Ormond Beach | Florida | 32174 | — |
| Hematology Oncology Associates of theTreasure Coast - Port St. Lucie | Port Saint Lucie | Florida | 34952 | — |
| Northwest Georgia Oncology Centers, P.C. | Marietta | Georgia | 30060 | — |
| Georgia Cancer Specialists - Tucker | Tucker | Georgia | 30084 | — |
| Silver Cross Hospital | Joliet | Illinois | 60432 | — |
| Gross Point Medical Center | Skokie | Illinois | 60077 | — |
| Kentucky Cancer Clinic | Pikeville | Kentucky | 41501 | — |
| Not listed | Grand Rapids | Michigan | 49503 | — |
| Hattiesburg Clinic, P.A. | Hattiesburg | Mississippi | 39401 | — |
| Columbia Comprehensive Cancer Care Clinic | Columbia | Missouri | 65201 | — |
| Bond Clinic | Rolla | Missouri | 65401 | — |
| Las Vegas Cancer Center | Las Vegas | Nevada | 89102 | — |
| Summit Medical Group, P.A. | Summit | New Jersey | 07901 | — |
| Gabrail Cancer Center - Canton Office | Canton | Ohio | 44718 | — |
| Oklahoma Oncology, Inc. - St. John Campus | Tulsa | Oklahoma | 74104 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| Santee Hematology Oncology | Sumter | South Carolina | 29150 | — |
| Clarksville Regional Hematology/Oncology Group | Clarksville | Tennessee | 37043 | — |
| Family Cancer Center | Collierville | Tennessee | 38017 | — |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Cancer Therapy and Research Center | San Antonio | Texas | 78229 | — |
| Virginia Oncology Care P.C. | Richlands | Virginia | 24641 | — |
| Highline Medical Oncology | Burien | Washington | 98166 | — |
| Rainier Oncology | Puyallup | Washington | 98372 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00054210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00054210 live on ClinicalTrials.gov.